Viewing Study NCT07022002


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2025-12-26 @ 2:34 AM
Study NCT ID: NCT07022002
Status: RECRUITING
Last Update Posted: 2025-08-03
First Post: 2025-06-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-07-30
Start Date Type: ACTUAL
Primary Completion Date: 2026-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-12-12
Completion Date Type: ESTIMATED
First Submit Date: 2025-06-06
First Submit QC Date: None
Study First Post Date: 2025-06-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-01
Last Update Post Date: 2025-08-03
Last Update Post Date Type: ACTUAL